Corpus ID: 491135

Establishment of cross-resistance profiles for new agents.

  title={Establishment of cross-resistance profiles for new agents.},
  author={F. Schabel and H. Skipper and M. Trader and W. R. Laster and D. Griswold and T. Corbett},
  journal={Cancer treatment reports},
  volume={67 10},
Sublines of murine leukemias (L1210 and P388) and solid tumors selected for resistance to representatives of all of the chemical and functional classes of clinically useful anticancer drugs have been isolated and established in serial in vivo passage and, in some cases, in vitro culture. Extensive resistance, cross-resistance, and collateral-sensitivity patterns have been established with most of the sublines of the drug-resistant murine leukemias under treatment with greater than 100 different… Expand
Studies on drug resistance in a human melanoma xenograft system.
  • R. Osieka
  • Medicine
  • Cancer treatment reviews
  • 1984
Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia
V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant
Murine L1210 and P388 Leukemias
Therapeutic Resistance in Leukemia
Collateral methotrexate resistance in cisplatin-selected murine leukemia cells.
  • A. Bhushan, M. Hacker, T. Tritton
  • Biology, Medicine
  • Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
  • 1999